The test was developed by researchers at the University of Alberta in Edmonton, Alberta, Canada.
Gastroenterologist Dr. Richard Fedorak and colorectal surgeon Dr. Haili Wang developed the urine test technology. The first version of the technology was tested on 1,200 patients and had an accuracy rate of 82 percent. A second version had an accuracy rate of 97 percent.
The test requires a nuclear magnetic resonance machine to detect the metabolites in frozen samples.
Related Articles on Colorectal Cancer:
Study: Beta Blocker Use Does Not Decrease Risk of Colorectal Cancer
AGA Members Provide Nearly 300 Free Colonoscopies During Colorectal Cancer Awareness Month
Patients Over 50 Give Three Reasons for Avoiding Colorectal Cancer Screenings
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
